Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, 300 Community Drive Manhasset, New York, United States, 11030.
Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, 300 Community Drive Manhasset, New York, United States, 11030.
J Pediatr Surg. 2019 Sep;54(9):1926-1928. doi: 10.1016/j.jpedsurg.2018.11.017. Epub 2018 Dec 27.
The incidence of Marfan syndrome in the general population is 0.3%. Two-thirds of patients with Marfan syndrome have concurrent pectus deformity. However, incidence of Marfan syndrome and cardiac abnormalities in patients presenting with an isolated pectus deformity remains unknown. We sought to establish the degree of association between pectus deformities and these abnormalities, and whether referral of these patients for cardiac and genetic workup is warranted.
Our pediatric surgery group refers patients with pectus deformities for genetic and cardiac evaluation. We examined 415 records from 2009 to 2016, and identified 241 patients with a chief complaint of a pectus deformity. Patient characteristics, echocardiogram results, Haller indices, and genetic results were analyzed.
The frequency of Marfan syndrome in our study was 5.3%. The incidence of Marfan was highest among patients with combined type pectus deformity (20%). Cardiac anomalies showed an overall incidence of 35%. Of those diagnosed with Marfan, 84% had cardiac abnormalities.
More than 5% of patients presenting with a chief complaint of pectus deformity will have a diagnosis of Marfan syndrome, compared to 0.3% in the general population. Approximately a third of this population will have cardiac abnormalities. Referral of patients with pectus deformities for evaluation for Marfan syndrome and cardiac abnormalities is appropriate.
Level IV.
马凡综合征在普通人群中的发病率为 0.3%。三分之二的马凡综合征患者同时伴有胸壁畸形。然而,患有孤立性胸壁畸形的患者中马凡综合征和心脏异常的发病率尚不清楚。我们旨在确定胸壁畸形与这些异常之间的关联程度,以及是否有必要将这些患者转介进行心脏和遗传检查。
我们的小儿外科学组将胸壁畸形患者转介进行遗传和心脏评估。我们检查了 2009 年至 2016 年的 415 份记录,并确定了 241 名以胸壁畸形为主要主诉的患者。分析了患者的特征、超声心动图结果、Haller 指数和遗传结果。
在我们的研究中,马凡综合征的发病率为 5.3%。复合型胸壁畸形患者的马凡发病率最高(20%)。心脏异常的总体发病率为 35%。在诊断为马凡的患者中,84%有心脏异常。
与普通人群中 0.3%的发病率相比,主诉为胸壁畸形的患者中,有 5%以上将被诊断为马凡综合征。该人群中有近三分之一存在心脏异常。将胸壁畸形患者转介进行马凡综合征和心脏异常评估是合理的。
IV 级。